Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 2/2015

01-04-2015 | Short Communication

Use of a Web-Based Survey to Facilitate Shared Decision Making for Patients Eligible for Cancer Screening

Authors: Charles D. Brackett, Stephen Kearing

Published in: The Patient - Patient-Centered Outcomes Research | Issue 2/2015

Login to get access

Abstract

Objective

Our aim was to facilitate shared decision making (SDM) during preventive visits by utilizing a web-based survey system to offer colorectal cancer (CRC) and prostate cancer screening decision aids (DAs) to appropriately identified patients prior to the visit.

Methods

Patients completed a web-based questionnaire before their preventive medicine appointment. Age- and gender-appropriate patients completed additional questions to determine eligibility for CRC or prostate-specific antigen (PSA) screening. Eligible patients were offered a choice of video or print DA, and completed questions assessing their knowledge, values, and preferences regarding the screening decision. Responses were summarized and fed forward to clinician and patient reports.

Results

Overall, 11,493 CRC and 4,384 PSA questionnaires were completed. Patient responses were used to identify those eligible for cancer-screening DAs: 2,187 (19 %) for CRC and 2,962 (68 %) for PSA; 15 % of eligible patients requested a DA. Many patients declined a DA because they indicated they “already know enough to make their decision” (34 % for CRC, 46 % for PSA).

Conclusion

A web-based questionnaire provides an efficient means to identify patients eligible for cancer screening decisions and to offer them DAs before an appointment. Pre-visit use of DAs along with reports giving feedback to patients and clinicians provides an opportunity for SDM to occur at the visit.
Appendix
Available only for authorised users
Literature
1.
go back to reference Screening for prostate cancer. US preventive services task force recommendation statement. Ann Intern Med. 2008;149:185–91.CrossRef Screening for prostate cancer. US preventive services task force recommendation statement. Ann Intern Med. 2008;149:185–91.CrossRef
2.
go back to reference American College of Physician. Screening for prostate cancer. Ann Intern Med. 1997;126:480–4.CrossRef American College of Physician. Screening for prostate cancer. Ann Intern Med. 1997;126:480–4.CrossRef
3.
go back to reference American Academy of Family Physicians. Appendix F, summary of policy recommendations for periodic health exam. In: AAFP reference manual. Kansas City: AAFP; 1998. p. 62. American Academy of Family Physicians. Appendix F, summary of policy recommendations for periodic health exam. In: AAFP reference manual. Kansas City: AAFP; 1998. p. 62.
4.
go back to reference Barry MJ, Mulley AG, Fowler FJ, Wennberg JW. Watchful waiting vs. immediate transurethral resection for symptomatic prostatism. JAMA. 1988;259:3010–7.CrossRefPubMed Barry MJ, Mulley AG, Fowler FJ, Wennberg JW. Watchful waiting vs. immediate transurethral resection for symptomatic prostatism. JAMA. 1988;259:3010–7.CrossRefPubMed
5.
go back to reference American Urological Association. Prostate specific antigen best practice policy. Oncology. 2000;14:267–80. American Urological Association. Prostate specific antigen best practice policy. Oncology. 2000;14:267–80.
6.
go back to reference US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129–31.CrossRef US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129–31.CrossRef
7.
go back to reference Barry M. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127–35.CrossRefPubMed Barry M. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127–35.CrossRefPubMed
8.
go back to reference O’Connor A, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. Br Med J. 2003;327:736–40.CrossRef O’Connor A, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. Br Med J. 2003;327:736–40.CrossRef
9.
go back to reference Sepucha K, Fowler FJ, Mulley AG. Policy support for patient centered care: the need for measurable improvements in decision quality. Health Affair. 2004;54–62. Sepucha K, Fowler FJ, Mulley AG. Policy support for patient centered care: the need for measurable improvements in decision quality. Health Affair. 2004;54–62.
10.
go back to reference Reuland DS, Pignone M. Improving the quality of decision-making processes for prostate cancer screening: progress and challenges. JAMA Intern Med. 2013;173:1713–4.PubMed Reuland DS, Pignone M. Improving the quality of decision-making processes for prostate cancer screening: progress and challenges. JAMA Intern Med. 2013;173:1713–4.PubMed
11.
go back to reference Stacey D, Bennett C, Barry M, Col N, Eden K, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431. Stacey D, Bennett C, Barry M, Col N, Eden K, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431.
12.
go back to reference Brackett C, Kearing S, Cochran N, Tosteson A, Brooks WB. Strategies for distributing cancer screening decision aids in primary care. Patient Educ Couns. 2010;78:166–8.CrossRefPubMed Brackett C, Kearing S, Cochran N, Tosteson A, Brooks WB. Strategies for distributing cancer screening decision aids in primary care. Patient Educ Couns. 2010;78:166–8.CrossRefPubMed
15.
go back to reference Schwartz LM, Woloshin S, Fowler FJ, et al. Enthusiasm for cancer screening in the United States. JAMA. 2004;29:71–8.CrossRef Schwartz LM, Woloshin S, Fowler FJ, et al. Enthusiasm for cancer screening in the United States. JAMA. 2004;29:71–8.CrossRef
16.
go back to reference Brackett C, Cochran N, Coutermarsh M, Kearing S, Clay K, Brooks WBB. Implementation and impact of two preventive medicine screening decision aids in primary care practice. Pittsburgh PA: Society for Medical Decision Making Annual Meeting; 2007. Brackett C, Cochran N, Coutermarsh M, Kearing S, Clay K, Brooks WBB. Implementation and impact of two preventive medicine screening decision aids in primary care practice. Pittsburgh PA: Society for Medical Decision Making Annual Meeting; 2007.
17.
go back to reference Frosch DL, May SG, Rendle KA, Tietbohl C, Elwyn G. Authoritarian physicians and patients’ fear of being labeled ‘difficult’ among key obstacles to shared decision making. Health Affair. 2012;31:1030–8.CrossRef Frosch DL, May SG, Rendle KA, Tietbohl C, Elwyn G. Authoritarian physicians and patients’ fear of being labeled ‘difficult’ among key obstacles to shared decision making. Health Affair. 2012;31:1030–8.CrossRef
Metadata
Title
Use of a Web-Based Survey to Facilitate Shared Decision Making for Patients Eligible for Cancer Screening
Authors
Charles D. Brackett
Stephen Kearing
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 2/2015
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-014-0079-7

Other articles of this Issue 2/2015

The Patient - Patient-Centered Outcomes Research 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine